Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2026.01.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Alba Boix-Amorós und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Arthritis, Psoriatic, Feces, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Innovative Medicines Initiative, Janssen Pharmaceuticals Inc, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
OBJECTIVES: There is growing evidence of microbial involvement in immune-mediated inflammatory diseases, including psoriatic arthritis (PsA) and inflammatory bowel disease (IBD). However, it remains unclear whether different PsA phenotypes exhibit distinct microbial profiles. Furthermore, up to 4% of patients with PsA have comorbid IBD, which often remains undiagnosed. We hypothesised that the gut microbiome distinguishes PsA subphenotypes and serves as a biomarker of IBD in patients with PsA independent of faecal calprotectin (fCAL). METHODS: We obtained samples from 192 patients with axial or peripheral PsA and no prior diagnosis of IBD enrolled in the EISER study. Patients with elevated fCAL and subclinical IBD symptoms underwent colonoscopy with intestinal biopsy. Stool samples were used to measure fCAL, and gut microbiome was characterised using shotgun metagenomics. Serum samples were used for cytokine profiling. RESULTS: Axial PsA had lower alpha diversity and loss of several commensals compared with peripheral PsA, as well as a depletion of microbial biotin and arginine metabolism and higher levels of IL-23, IL-17F, and IL-8. Five subjects had newly diagnosed IBD which was characterised by a depletion of tryptophan and vitamin B6 metabolism. They also showed significant enrichment of several taxa compared to non-IBD and with a larger effect size than fCAL. CONCLUSIONS: Our results identify a distinct microbiome and immune profile in axial PsA, with lower microbiome diversity, a depletion of commensals and protective microbial mechanisms, and higher levels of some proinflammatory cytokines. In patients with newly diagnosed IBD, we identified microbial taxa associated with the condition yet independent of fCAL, the current clinical standard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, USA.
- Departamento de Gastroenterología, Hospital General Universitario Dr. Balmis, ISABIAL y CIBERehd, Alicante, Spain.
- Departamento de Gastroenterología, Hospital Universitario Galdakao-Usansolo, Instituto de Investigación Sanitaria Biobizkaia, Galdakao Bizkaia, Spain.
- Servicio Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
- Departamento de Reumatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Förderung
- Innovative Medicines Initiative
- Janssen Pharmaceuticals Inc
- Horizon 2020 Framework Programme
Zitieren
APA
Boix-Amorós, A., Bu, K., Blank, R. B., Cantor, A., Gutiérrez-Casbas, A., Rodríguez-Lago, I., Marin-Jimenez, I., Sanz, J., Masmitja, J. G., Trujillo, E., Muñoz, M. C., Vivar, M. L. G., Carrillo, M., Hernández, M. V. H., Calvet, X., Salaet, M. A., Romero, M. I., García, A. B., Pérez, S., …, & Clemente, J. C. (2026). Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.01.018
Vancouver
Boix-Amorós A, Bu K, Blank RB, Cantor A, Gutiérrez-Casbas A, Rodríguez-Lago I, et al. Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.01.018
BibTeX
@article{BoixAmors2026,
author = {Boix-Amorós, Alba and Bu, Kevin and Blank, Rebecca B and Cantor, Adam and Gutiérrez-Casbas, Ana and Rodríguez-Lago, Iago and Marin-Jimenez, Ignacio and Sanz, Jesus and Masmitja, Jordi Gratacos and Trujillo, Elisa and Muñoz, María Carmen and Vivar, María Luz García and Carrillo, Marta and Hernández, María Vanesa Hernández and Calvet, Xavier and Salaet, Marta Arévalo and Romero, Marta Izquierdo and García, Anahy Brandy and Pérez, Sandra and Llorente, Jose Francisco García and Gonzalez-Lama, Yago and Argumánez, Carolina Merino and Plaza, Zulema and Domínguez, Marta and Cañete, Juan D and Diaz-Gonzalez, Jose Federico and Scher, Jose U and Clemente, Jose C},
title = {Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2026.01.018}
}
EUVIMED